Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE).
about
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular TrialsMultiple risk factor intervention reduces carotid atherosclerosis in patients with type 2 diabetes.Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study.Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes.Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial.Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observatClinical evidence for the earlier initiation of insulin therapy in type 2 diabetesPrediabetes and associated disorders.Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.Effect of basal insulin therapy on vascular endothelial function and adipokine profiles in people with Type 2 diabetes.A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus.The Effects of Omega-3 and Vitamin E Co-supplementation on Carotid Intima-media Thickness and Inflammatory Factors in Patients with Polycystic Ovary Syndrome
P2860
Q26767164-8F7486B0-AB83-47F2-B289-7E96B7482BAFQ33698160-0C6039D9-839E-4268-842C-E06109F8BF6EQ34333373-CC13787C-7EC2-4CC1-9CF3-A49C4489FA0DQ35044151-ABC92658-1936-4363-A722-6E9D0210FB97Q36633079-9D91E80B-8389-4FFA-919B-E4F890FB3EBFQ37356328-1D913780-9019-48E4-BB87-A380B7B670C6Q38115799-E18950D1-59DB-4078-936D-5A3A40388B4EQ38257985-993E70AE-0C52-41C5-82E4-7288F7971BB4Q38524435-E4D7D78B-CAEC-4FAE-91A6-84E2F3DA8575Q51285007-8D2D7D22-C8B7-44EA-82E3-6CD251559C55Q55162068-D97DE213-10A0-4633-9DAB-20F45F35EF16Q58571873-A049E24F-C82E-4E0B-8FF9-F9712BE0903B
P2860
Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of insulin glargine and ...... aluation study (ORIGIN-GRACE).
@en
Effect of insulin glargine and ...... is continuing evaluation study
@nl
type
label
Effect of insulin glargine and ...... aluation study (ORIGIN-GRACE).
@en
Effect of insulin glargine and ...... is continuing evaluation study
@nl
prefLabel
Effect of insulin glargine and ...... aluation study (ORIGIN-GRACE).
@en
Effect of insulin glargine and ...... is continuing evaluation study
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Effect of insulin glargine and ...... aluation study (ORIGIN-GRACE).
@en
P2093
Ambady Ramachandran
Eva M Lonn
GRACE and ORIGIN Investigators
Jackie Bosch
Lars Ryden
Leanne Dyal
Matthew J McQueen
Nicolae Hâncu
Patricio Lopez-Jaramillo
Rafael Diaz
P2860
P304
P356
10.2337/DC12-2129
P407
P577
2013-04-05T00:00:00Z